Agilon Health (AGL) Cash from Investing Activities (2020 - 2026)

Agilon Health (AGL) has reported Cash from Investing Activities for 7 consecutive years, with $19.3 million the latest figure, recorded in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $19.3 million, up 183.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $131.0 million (up 100.37% YoY), and the FY2025 annual result was $88.6 million, down 36.66% from the prior year.
• Cash from Investing Activities was $19.3 million for Q1 2026 at Agilon Health, down from $22.6 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $70.5 million in Q2 2025 and troughed at -$296.6 million in Q2 2022.
• Average Cash from Investing Activities over 5 years is -$14.2 million, with a median of $18.2 million recorded in 2024.
• Year-over-year, Cash from Investing Activities sank 1032.19% in 2022 and soared 1174.58% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$8.0 million in 2022, then surged by 72.36% to -$2.2 million in 2023, then jumped by 1174.58% to $23.7 million in 2024, then retreated by 4.6% to $22.6 million in 2025, then slipped by 14.66% to $19.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $19.3 million in Q1 2026, $22.6 million in Q4 2025, and $18.7 million in Q3 2025.